Home Products Most Popular Contact
No items in your cart.
The page below is a sample from the LabCE course Clostridium difficile Infection (CDI): Overview, Laboratory Tests and Updated Guidelines.. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Clostridium difficile Infection (CDI): Overview, Laboratory Tests and Updated Guidelines. (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 123 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart


Clostridium difficile infection: a review of current and emerging therapies, A Ofosu, Ann gastroenterol, 2016, 147-1`54, available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805733/
C Difficile Overview, Cdiff foundation, available athttps://cdifffoundation.org/
C difficile infection: Overview, Symptoms, Causes, Risk Factors, and Prevention, Mayo Clinic, available at https://www.mayoclinic.org/diseases-co nditions/c-difficile/symptoms-causes/syc-20351691?p=1
C difficile, Diagnosis and Treatment, Mayo Clinic, available at https://www.mayoclinic.org/diseases-conditions/c-difficile/diagnosis-treatment/drc-20351697
Clostridium difficile infections, Medline Plus, U.S. National Library of Medicine, available at https://medlineplus.gov/clostridiumdifficileinfections.html
C. Difficile Infection, Am College of GI (ACG), available at http://patients.gi.org/topics/c-difficile-infection/
Clostridium difficile infection in adults: Clinical manifestations and diagnosis, Kelly C P et al, Uptodate, updated June, 2018, available athttps://www.uptodate.com/contents/clostridium-difficile-infection-in-adults-clinical-manifestations-and-diagnosis#H22
Clostridium difficile infections. Centers for Disease Control and Prevention Web site.https://www.cdc.gov/hai/organisms/cdiff/cdiff_infect.html.
Clostridium difficile infections, CDC, Overview, available at Centers for Disease Control and Prevention. Clostridium difficile infection.
Snydman DR, McDermott LA, Jenkins SG, et al. Epidemiologic trends in Clostridium difficile isolate ribotypes in United States from 2010 to 2014. Open Forum Infectious Diseases. 2017;4(suppl_1):S391-S391.
Schutze GE, Willoughby RE, Committee on Infectious Diseases, American Academy of Pediatrics. Clostridium difficile infection in infants and children. Pediatrics. 2013;131;196-200.
Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 209;58:403-410.
Clostridium Difficile Colitis (Antibiotic-Associated Colitis) Dennis Lee MD, MedicineNet, available at https://www.medicinenet.com/clostridium_difficile_colitis/article.htm#how_is_clostridium_difficile_colitis_treated
Tschudin-Sutter S, Kuijper EJ, Durovic A, et al. Guidance document for prevention of Clostridium difficile infection in acute healthcare settings. Clin Microbioland Infect. 2018;Mar 2. pii: S1198-743X(18)30195-2.
Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. O’Conner JR et al, Gastroenterology, 2009 May;136(6):1913-24. Available at https://www.ncbi.nlm.nih.gov/pubmed/19457419

The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins, Chen S et al, Toxins (Basel), 2015 Dec; 7(12): 5254–5267. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690124/
Lim SK, Stuart RL, Mackin KE, et al. Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain. Clin Infect Dis. 2014;58(12):1723-1730.
Kociolek LK, Gerding DN. Clinical utility of laboratory detection of Clostridium difficile strain BI/NAP1/027. J Clin Microbiol. 2016;54(1):19-24.
Guidelines and Studies Suggest Improved Approaches to C difficile testing, MLO, available at https://www.mlo-online.com/new-guidelines-and-studies-suggest-improved-approaches-to-cdifficile-testing
Current knowledge on the laboratory diagnosis of Clostridium difficile infection: Review of diagnostic testing: Adrián Martínez-Meléndez, et al,World J Gastroenterol. Mar 7, 2017; 23(9): 1552-1567 available athttps://www.wjgnet.com/1007-9327/full/v23/i9/1552.htm
Clostridium difficile and C difficile toxin testing, Labtestsonline, AACC, available at https://labtestsonline.org/tests/clostridium-difficile-and-c-difficile-toxin-testing

Clostridium difficile Diagnostic Testing: Quest Diagnostics, available at https://education.questdiagnostics.com/faq/FAQ136

Planche TD, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicenter diagnostic validation study of difficile infection. The Lancet. 2013;13(11):936-945.
Accuracy of Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection: A meta analysis, Bai Y et al,Published: October 9, 2017, available at https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0185891
Package insert TECHLAB® C. DIFF QUIK CHEK COMPLETE®. http://www.alere.com/en/home/product-details/c-diff-quik-chek-complete.html
C Diff Quik Chek Complete: product details, Alere, available at https://www.alere.com/en/home/product-details/c-diff-quik-chek-complete.html
The Xpect C difficile Toxin A/B Test: Remel, Product Information, available at https://www.thermofisher.com/order/catalog/product/R24640
FDA review of C. DIFF QUIK CHEK COMPLETE™ available at
Cohen SH, Gerding DN, Johnson S, et al. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-455.

New IDSA/SHEA Clostridium Difficile Guidelines ,Clin Infect Dis; ePub 2018 Feb 15; McDonald, et al: Published,February 26, 2018 , available athttps://www.mdedge.com/idpractitioner/clinical-edge/summary/antimicrobial-resistance/new-idsa/shea-clostridium-difficile
McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). [Published online ahead of print February 15, 2018]. Clin Infect Dis. doi:10.1093/cid/cix1085.
C Diff Clinical Practices Guidelines, 2017, C Diff Foundation, available at https://cdifffoundation.org/2018/02/15/cdiffclinical-practices-guidelines2017/

New guidelines and studies suggest improved approaches to C. difficile testing, Sherry A. Dunbar, June 21, 2018, MLO, available at https://www.mlo-online.com/new-guidelines-and-studies-suggest-improved-approaches-to-cdifficile-testing
Roecker A, et al, Gastrointestinal Infections and Enterotoxigenic Poisoning: Taken from DiPiro JT, et al, Pharmacotherapy: A Pathophysiologic Approach, 10e New York, NY: McGraw-Hill; available athttps://www.pharmacytimes.com/contributor/ayesha-khan-pharmd-bcps/2018/03/practice-pearls-from-the-2018-clostridium-difficile-treatment-guidelines

Multistep algorithm testing accurately identifies C. diff patients who need treatment, Jodie Lee, July 2018, MLO, available at
Other References:
Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for the diagnosis, treatment and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108:478-498.
American Society for Microbiology. A practical guidance document for the laboratory detection of toxigenic Clostridium difficile. Published September 21, 2010, available at https://www.asm.org/images/pdf/Clinical/clostridiumdifficile9-21.pdf.
Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 209;58:403-410.
Gade R, Turett G. The utility of repeated stool toxin testing for diagnosing Clostridium difficile colitis. South Med J 2009; 102:1007